doi: 10.3389/fphar.2025.1618079 Received 28 April 2025 Accepted 08 July 2025 Published 24 July 2025 Volume 16 - 2025 Edited by Karuna Rasineni, University of Nebraska Medical Center, United States Reviewed by Yang Yang, Chinese PLA General Hospital, China Asher Rajkumar Rajan, University of Nebraska Medical Center, United States Updates Copyright 2025 Xie, Yang, Tian and Chen
Drugs: Compounded semaglutide, compounded tirzepatide (both injectable and oral), plus brand-name Ozempic and Zepbound
Sydney, a former competitive dancer, tried everything to feel like herself againuntil microdosing a GLP-1 helped her unlock lasting results
Its ability to reduce appetite, promote fat loss, and improve overall metabolic health makes it a revolutionary treatment for individuals struggling with obesity and type 2 diabetes
It's actually, I don't have those hunger cravings